Bone Graft And Substitute Market Report
Bone Graft and Substitute Market, By Material Type (Allografts, Synthetics, Other), Application (Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, Spinal Fusion), End-User (Hospital, Dental Clinic), and Region - COVID-19 Impact Analysis and Forecast to 2026.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global Bone Graft and Substitute market. The historic years considered for the study are 2016-2019, the base year is 2020, the estimated year is 2021, and the forecast period is 2022-2026.
Bone Graft and Substitute Market, By Material Type (Allografts, Synthetics, Other), Application (Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, Spinal Fusion), End-User (Hospital, Dental Clinic), and Region...
Impact of COVID-19 on Bone Graft And Substitute Market
Covid-19 has impacted the market dynamics, competition, and global supply chain. The revenues have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition.
Note: The summary below might not have included insights on covid impact since we have large number of reports.
The Bone Graft and Substitute Market are projected to grow from USD 2.8 billion in 2020 to USD 3.9 billion by 2026 at a CAGR of around 5.7% during the forecast period.
Bone grafts are defined as implantable materials, which promote bone formation, bone healing, and osseous reconstruction due to their superior properties including osteogenic, osteoconductive, and osteoinductive. Bone grafts are also used to fill voids in case of the absence of bones.
Key players operating in the Bone Graft and Substitute market are-
The growth of the global bone graft and substitute market is primarily driven by increasing incidences of musculoskeletal disorders across the globe. Growing emphasis on the development of biocompatible synthetic bone grafts is expected to drive market growth at a significant rate during the review period. In addition to this, surging demand for advanced products is likely to create lucrative opportunities for the players operating in the global bone graft and substitute market in the coming years.
By end-user, the bone graft and substitute market has been bifurcated into hospitals and dental clinics. The hospital segment accounted for the largest market share in 2020 and is projected to register significant growth during the review period. The segment can be attributed to the availability of required infrastructure, technical expertise, and skilled staff.
By region, the North American market accounted for the largest market share in 2020 and is projected to grow at a robust CAGR during the review period. This can be attributed to the rising number of people suffering from orthopedic disorders coupled with expanding geriatric populace and the presence of key market players such as Zimmer Biomet (US) and Dentsply Sirona (US). The market growth in Asia-Pacific is expected to be driven by the increasing incidence of accidental injuries and rising medical tourism in developing countries.
The covid-19 outbreak posed significant challenges across verticals worldwide. It impacted the growth of the bone graft and substitute market negatively as the healthcare solutions other than covid-19 treatment declined due to fear of coronavirus infection. Also, supply chain disruptions due to the imposition of lockdown affected the product availability on time and thus, affected the market growth.
Here is the list of the group of customers that the bone graft and substitute market hopes to have the greatest opportunity to convert-
Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at firstname.lastname@example.org.
The bone graft and substitute market is expected to witness an impressive growth of 5.7% CAGR in the coming years.
Zimmer Biomet (US), Medtronic plc (Ireland), Aimedic MMT (Japan), Dentsply Sirona (US), DePuy Synthes (US), Straumann (Switzerland), botiss medical AG (Germany), Biomatlante (France), Maxigen Biotech Inc. (Taiwan), B. Braun (Germany), BioMimetic Therapeutics, LLC (US), CryoLife, Inc. (US), Globus Medical, Inc. (US), GRAFTYS (France), Integra Life Sciences (US) and Johnson & Johnson (US) are among the key players in the bone graft and substitute market.
The bone graft and substitute market size is expected to reach USD 3.9 billion in the foreseeable future.
The hospital segment is expected to register significant growth in the bone graft and substitute market in the coming years.
North America accounted for the largest share in the bone graft and substitute market in 2020.
Bone graft and substitute distributors, Bone graft and substitute suppliers, Bone graft and substitute manufacturers, Logistics organizations, Government bodies are the target audience in the bone graft and substitute market.